Pfizer announces 130 jobs across Irish operations over next year
27 October 2015
Pfizer is creating 130 jobs across three manufacturing sites in Ireland including Grange Castle in Dublin and Little Island and Ringaskiddy in Cork, and a recruitment drive is under way. Pfizer employs about 3,200 people at six sites here across manufacturing, shared services, R&D, treasury and commercial operations and has invested $7 billion in operations in the country since 1969.
Dr Paul Duffy, vice-president, Pfizer, said: “Pharmaceutical manufacturing in Ireland continues to perform well contributing strongly to exports and economic growth, and providing good careers and jobs. Students should give strong consideration to studying STEM subjects all of which provide a route into pharmaceutical manufacturing.
“This provides a good career path but also provides a chance to be part of delivering innovative medicines to patients to help treat devastating diseases. Pfizer is one of Ireland’s leading employers and economic contributors. Our sites in Ireland manufacture some of Pfizer’s leading and newest medicines for export globally.”
Grange Castle based in west Dublin is looking to recruit across multiple functions including process scientists; process/equipment engineers; automation engineers; operations specialists; process technicians; quality analysts and project managers.
Pfizer Grange Castle is one of Pfizer’s leading biologic manufacturing sites globally with state of the art technologies. The site manufactures highly specialised and complex medicines and vaccines involving large-scale mammalian cell culture; protein purification; aseptic/ sterile manufacturing and vaccines conjugation. The site successfully secured $300 million in investment in recent years to expand production capacity.
Julien Deneve, site lead, Grange Castle, said: “Pfizer Grange Castle is delighted to announce we are recruiting 90 very good roles. We are looking for candidates to join our world-class colleagues in this innovative, exciting and growing organisation. The Pfizer Grange Castle site is a leading world-class facility in the Pfizer global network and is one of the largest integrated biotechnology plants in the world. The type of work conducted on the site is highly specialised and requires top level people across the fields of science, engineering and biotechnology.”
The Ringaskiddy and Little Island sites also have recruitment activity under way to fill more than 40 positions in Cork. These roles include process operators, mechanical and electrical/instrumentation craft, process engineers, process chemists, and quality control analysts.
Pfizer Ringaskiddy recently secured $30 million investment to develop specialist new capability to manufacture some of Pfizer’s newest cancer medicines and other future pipeline medicines. The investment enabled the introduction of new innovative technologies which required more specialised R&D skills.
Pfizer is prioritising its research and development efforts in areas where we can make the biggest difference to health and social care burdens: immunology and inflammation, oncology, cardiovascular and metabolic diseases, neuroscience and pain, and vaccines. Pfizer’s pipeline currently comprises more than 80 innovative therapies, including potentially first-in-class vaccines for two deadly hospital-acquired infections, new antibodies for lupus and high cholesterol and the next-generation of targeted therapies for cancer.
In oncology, we continue to build a strong portfolio of potential cancer therapies and we are also advancing our pipeline assets in rare diseases and personalised medicines. Specialised efforts in rare diseases also illustrate our dedication to developing and delivering innovative medicines and vaccines that will benefit patients around the world.http://www.engineersjournal.ie/2015/10/27/pfizer-announces-130-jobs-across-irish-operations-over-next-year/http://www.engineersjournal.ie/wp-content/uploads/2015/10/aaanews3.pnghttp://www.engineersjournal.ie/wp-content/uploads/2015/10/aaanews3-300x252.pngNewsjobs,Pfizer,pharma,STEM